Tags Posts tagged with "$NDEV"

$NDEV

0 1299

Novus Executes Agency Sales Agreement With Senior Healthcare Benefits

MIAMI, FL–(Marketwired – Feb 4, 2015) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of healthcare plans known as “Novus MedPlan,” is proud to announce we have executed an insurance sales agency contract with Senior Healthcare Benefits Group (Senior) http://www.seniorhealthcarenow.com. Senior will market “Novus’s MedPlan” benefits packages to registered medical marijuana (MMJ) patients in the state of Arizona. The Agreement between Novus and Senior is a flat 25% commission rate, per patient per month.

Frank Labrozzi, CEO, states, “Novus has completed our procurement of Arizona Providers within the MMJ and Alternative Medicines sectors and Novus is ready to deliver wellness programs to our member patients. Senior’s efforts will begin an outreach program to participating insurance brokers, independent insurance agencies and also engage medium to large corporations for comprehensive benefits packages. Senior’s target market is the 80,000 + qualified and registered patients in Arizona, including veterans diagnosed with PTSD who meet the criteria for MMJ wellness programs.”

Senior’s CEO, John Reardon, states, “We encourage and welcome other agencies in the insurance space to contact us so we can make this endeavor mutually beneficial both monetarily, and even most importantly, give Arizona patients the wellness programs which they deserve.”

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the wellness and medical marijuana industries in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About Senior Healthcare Benefits Group.

Senior has specialized insurance agents that “help patients find healthcare plans” and to make sure patients receive the coverage which they need. Headquartered in Melville, NY, Senior’s goal is to work with MMJ patients throughout the entire process of procuring the appropriate health insurance plan. Senior listens to patients concerns, explains options, and makes recommendations without pressure, then aids in the enrollment process. Senior’s approach is to make sure patients and their loved ones are not paying the high cost of medicinal meds. For more information on Senior Healthcare Benefits Group you can contact us through our website, or email them at info@seniorhealthcarenow.com or give us a call at 631-393-5019.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

Senior Healthcare Benefits Group
Website: http://www.seniorhealthcarenow.com
Email: Email Contact
Phone: 631-393-5019
Attention: John Reardon

0 1616

Novus Acquisition & Development Corp. CEO Returns 90 Million Personal Shares to Treasury

MIAMI, FL–(Marketwired – Jan 16, 2015) – Novus Acquisition & Development Corp. (OTC PINK:NDEV), a provider of health and wellness savings plans through its wholly-owned subsidiary Novus Medical Group Inc., today announced that Chief Executive Officer Frank Labrozzi has returned 90 million of his personal common shares of NDEV to the company treasury.

After the return of 90,000,000 common shares to treasury the reduction of issued and outstanding will go from 178,503,624 shares of common stock to 88,503,624 issued and outstanding, a 50% reduction. The return of these shares demonstrates management’s desire to maintain a capital structure that supports growth without increasing the number of authorized or outstanding shares.

“By returning 90 million of my own shares back to treasury benefits existing shareholders position with an increase by around 50% in total,” said Novus Acquisition & Development Corp. CEO Frank Labrozzi. “We look forward to continuing to enhance value and transparency for both existing and future shareholders. And also shareholders should be aware that this is not any shape or form a reverse split; it’s me sending back a portion of my position in NDEV to treasury.”

As outlined in previous press releases, the Company intends to file Form 10 to become a fully-reporting company traded on the OTCQB this month in order to further enhance shareholder value and transparency. Management continues to work toward achieving these goals, while simultaneously expanding the Novus MedPlan network to include new states and practitioners in the medical marijuana and integrative medicine industries.

About Novus Acquisition & Development Corp.

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

0 1241

Novus Is Building Proprietary Software System to Handle Membership Growth

MIAMI, FL–(Marketwired – Dec 29, 2014) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, “Novus MedPlan,” announces that it has retained PR Revolution (http://www.prrevolution.com) to build a proprietary software platform to handle rapid growth.

“Because of our vast response to the Novus MedPlan enrollment, which opened in October, Novus has retained PR Revolution to rebrand the current Novus Medical Group website to help facilitate our growth. The new website will allow patients to be connected to providers in a seamless fashion,” said Frank Labrozzi, Chairman of Novus. “The benefits of our software will allow Novus to continue to meet the needs of our growing Provider and Patient network and we anticipate the completion of the software in January.” In addition, the Company is moving forward with the filing of the Form 10 with SEC to be recognized as a fully reporting OTCQB company in January 2015.

“We are excited to have been awarded the development project for Novus MedPlan. This is an exciting project for our entire team and we are looking forward to the final product,” said Adam Segall, President of PR Revolution.

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense, put up for sale, put on the market, vend, deliver, supply, circulate, or trade cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

 The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About PR Revolution

PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm’s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visithttp://www.prrevolution.com for more information.

Safe Harbor:
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
For Investor Relations contact:
Main Tel: (855) 422-4463
Email: Email Contact

Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

1 1544

Novus Teams Up With PR Revolution to Execute Go-to-Market Strategy

MIAMI, FL–(Marketwired – Dec 17, 2014) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, “Novus MedPlan,” is proud to announce that it has retained PR Revolution (www.prrevolution.com) as its public relations and marketing agency of record. The agency will be responsible for managing print and local media relations as well as marketing and branding direction for the Novus MedPlan as Novus continues to expand throughout the country.

“We are very pleased to have the support of PR Revolution as we continue to expand our provider footprint,” stated Frank Labrozzi, Chairman of Novus. “With extensive public relations, marketing experience and substantial success for their clients in the cannabis and insurance industries, PR Revolution is the ideal partner to help generate excitement about Novus MedPlan and our providers.”

Novus MedPlan is a discount program designed to save medical marijuana patients money on their medicinals as well as save all consumers money on holistic and alternative medicines. Members receive access to an exclusive provider network that Novus is building throughout the country. The network is being strategically developed to provide easy access to providers no matter where network members are located throughout the states in which the Novus MedPlan is available.

“Novus MedPlan is a great concept and its timing is perfect with the rapid expansion of the cannabis industry. It also fits perfectly within our cannabis client portfolio of clients, which is a sector our agency has been able to have tremendous success in over the past few years with feature stories on CNBC and FOX Business, as well as in numerous print publications such as Forbes, Time Magazine, US Today, Fast Company and Huffington Post,” says Elyse Segall, CEO of PR Revolution.

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About PR Revolution
PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm’s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visithttp://www.prrevolution.com for more information.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
For Investor Relations contact:
Main Tel: (855) 422-4463
Email: Email Contact

Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

0 1573

Novus Reaches Milestone in Providing Affordable Medicinal Marijuana Treatment to Arizona Patients Statewide

MIAMI, FL–(Marketwired – Dec 15, 2014) – Novus Acquisition & Development Corp (OTC PINK:NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, “Novus MedPlan,” is proud to announce that we have completed our strategic network provider outreach in Arizona. With the awareness that PR Revolution (http://www.prrevolution.com), a public relations and marketing agency who specializes in the cannabis sector, delivered for Novus at the National Marijuana Business Conference last month, Novus was able to exceed expectations for provider enrollment, connect with new providers and execute agreements with more-than-willing dispensaries and wellness clinics. As a result, Novus MedPlan is now ready to assist patients in more states than ever before.

“We have completed our strategic network provider outreach and geographically aligned ourselves throughout the state of Arizona to ensure all of our members have access to Medical Marijuana Clinics and wellness providers within their region, regardless of where in the state they reside,” said Andrea Lopez, Novus President and CEO. “The Novus team is energized about exceeding provider enrollment in Arizona and is continuing its expansion of our Provider Network in Colorado. We plan to continue to build our provider network to strengthen our footprint throughout the country.”

The Novus MedPlan Program is a revolutionary approach to reducing healthcare costs within the MMJ and wellness industry. Individuals and their families can save money on the cost of healthcare-related products and services that are not covered by standard healthcare programs. Patients’ cost-saving plan will be 20% to 50% off for members of Novus MedPlan, which include: doctors’ consultations, alternative medication and medical marijuana in approved states; all for a low fee of $19.95 per month. All patients have the ability to complete their enrollment online 24 hours a day at http://www.novusmedicalgroup.com.

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist. The Company also plans to offer physicians’ education programs, pharmaceutical R&D, compliance, and business development services within the industry.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

About PR Revolution
PR Revolution is a full-service public relations and digital marketing agency, with offices in New York City and Livingston, New Jersey. The firm’s seasoned and diverse team offers clients extensive expertise across multiple sectors including cannabis, insurance, fashion and beauty, media and entertainment, food and beverage, travel and hospitality as well as technology. Visithttp://www.prrevolution.com for more information.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
For Investor Relations contact:
Main Tel: (855) 422-4463
Email: Email Contact

Contact
Novus Acquisition & Development Corp
Gary F. Labrozzi
CEO
855-228-7355
Website: www.ndev.biz or www.novusmedicalgroup.com
Email: Email Contact

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements